We are live on ! Find out more
PI

PineBridge Investments Portfolio holdings

AUM $11.9B
1-Year Est. Return 23.42%
This Fund
S&P 500
This Quarter Est. Return
-14.08%
1 Year Est. Return
+23.42%
3 Year Est. Return
+86.73%
5 Year Est. Return
+113.15%
10 Year Est. Return
+399.75%
AUM
$7.95B
AUM Growth
-$1.38B
Cap. Flow
+$77.6M
Cap. Flow %
0.98%
Top 10 Hldgs %
27.67%
Holding
801
New
75
Increased
328
Reduced
297
Closed
79

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$63.4M
2
HON icon
Honeywell
HON
+$40M
3
LH icon
Labcorp
LH
+$39.1M
4
WMT icon
Walmart Inc
WMT
+$39M
5
MCD icon
McDonald's
MCD
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 24.23%
2 Healthcare 13.36%
3 Financials 12.16%
4 Consumer Discretionary 9.7%
5 Communication Services 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$183B
$57.4M 0.72%
528,587
+117,062
+28% +$13.3M
VZ icon
27
Verizon
VZ
$193B
$54.9M 0.69%
1,080,803
+99,953
+10% +$5.06M
CSCO icon
28
Cisco
CSCO
$448B
$53.8M 0.68%
1,261,316
-60,866
-5% -$2.91M
ABBV icon
29
AbbVie
ABBV
$455B
$52.4M 0.66%
342,070
+21,936
+7% +$3.35M
LOW icon
30
Lowe's Companies
LOW
$118B
$51.9M 0.65%
297,135
+7,710
+3% +$1.49M
USB icon
31
US Bancorp
USB
$98B
$51.4M 0.65%
1,117,636
-160,624
-13% -$8.02M
TXN icon
32
Texas Instruments
TXN
$255B
$48.3M 0.61%
314,666
-37,374
-11% -$6.29M
WY icon
33
Weyerhaeuser
WY
$16.9B
$44.7M 0.56%
1,348,159
+487,618
+57% +$18.6M
CVX icon
34
Chevron
CVX
$383B
$44.6M 0.56%
307,869
+53,453
+21% +$8.84M
CVS icon
35
CVS Health
CVS
$134B
$44.5M 0.56%
480,748
+341,588
+245% +$33.3M
MMM icon
36
3M
MMM
$90.8B
$43.8M 0.55%
404,876
+16,986
+4% +$2.05M
PH icon
37
Parker-Hannifin
PH
$121B
$43.5M 0.55%
176,827
+19,498
+12% +$5.22M
CBRE icon
38
CBRE Group
CBRE
$43.8B
$42.6M 0.54%
578,613
+318,241
+122% +$25.6M
HSY icon
39
Hershey
HSY
$35.9B
$42.5M 0.54%
197,633
+38,714
+24% +$8.44M
AXP icon
40
American Express
AXP
$228B
$42.1M 0.53%
303,847
+47,828
+19% +$7.9M
GWW icon
41
W.W. Grainger
GWW
$64B
$40.7M 0.51%
89,647
+37,513
+72% +$18.2M
REGN icon
42
Regeneron Pharmaceuticals
REGN
$77.4B
$40.7M 0.51%
68,874
+47,635
+224% +$31M
JPM icon
43
JPMorgan Chase
JPM
$933B
$40.6M 0.51%
360,167
-511,393
-59% -$63.4M
SNPS icon
44
Synopsys
SNPS
$71.3B
$40.4M 0.51%
133,034
+64,666
+95% +$19.5M
BAC icon
45
Bank of America
BAC
$433B
$40.2M 0.51%
1,291,250
-641,841
-33% -$23.1M
AMGN icon
46
Amgen
AMGN
$209B
$39.5M 0.5%
162,207
-55,268
-25% -$13.5M
DOW icon
47
Dow Inc
DOW
$21.7B
$38.4M 0.48%
744,136
-4,149
-0.6% -$266K
MCK icon
48
McKesson
MCK
$101B
$38.3M 0.48%
117,389
+47,129
+67% +$15.1M
BMY icon
49
Bristol-Myers Squibb
BMY
$132B
$37.3M 0.47%
484,396
+262,382
+118% +$20M
ELV icon
50
Elevance Health
ELV
$81.6B
$36.4M 0.46%
75,413
+1,385
+2% +$685K

Similar funds

PineBridge Investments's Q2 2022 Portfolio in Review

As of Q2 2022, PineBridge Investments held 801 positions worth $7.95B, down 15% from $9.32B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

PineBridge Investments's Q2 2022 filing shows 75 new, 328 increased, 297 reduced and 79 closed positions. Its largest new stake was Williams Companies: 395,247 shares worth $12.3M. The largest sale was JPMorgan Chase, an estimated $63.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • PineBridge Investments's largest Q2 2022 buy was Williams Companies: 395,247 shares worth $12.3M.
  • PineBridge Investments added most to CVS Health in Q2 2022, an estimated $33.3M increase.
  • PineBridge Investments's biggest Q2 2022 reduction was JPMorgan Chase, cutting an estimated $63.4M.
  • PineBridge Investments fully exited Labcorp in Q2 2022, selling an estimated $39.1M.
  • PineBridge Investments's ten largest holdings make up 28% of its $7.95B portfolio in Q2 2022.
  • PineBridge Investments opened 75 new positions and closed 79 in Q2 2022.
  • PineBridge Investments's portfolio value fell 15% quarter-over-quarter to $7.95B.

Based on PineBridge Investments's 13F filing for Q2 2022, filed 5 Aug 2022.